From the previous sections, we found that CEP55 is highly expressed in tumor tissue and predicts a poor clinical outcome; therefore, we aimed to correlate that with the immune cells that preferentially infiltrate the tumor in a correlation with CEP55 upregulation where we targeted two types of cells with reported immunosuppressive activity, namely, MDSCs and CAFs. This evidence concerns the gene CEP55 and neoplasm.